Mitochondrial DNA Mutation and Oxidative Stress

  • Kim, Tae-Ho (Biological Resources Coordination Division, National Institute of Biological Resources) ;
  • Kim, Hans-H. (College of Medicine, SUNY Upstate Medical University) ;
  • Joo, Hyun (Department of Physiology and Integrated Biosystems, School of Medicine, Inje University)
  • Received : 2011.12.28
  • Accepted : 2011.12.30
  • Published : 2011.12.30


Defects in mitochondrial DNA (mtDNA) cause many human diseases and are critical factors that contribute to aging. The mechanisms of maternally-inherited mtDNA mutations are well studied. However, the role of acquired mutations during the aging process is still poorly understood. The most plausible mechanism is that increased reactive oxygen species (ROS) may affect the opening of mitochondrial voltage dependent anion channel (VDAC) and thus results in damage to mtDNA. This review focuses on recent trends in mtDNA research and the mutations that appear to be associated with increased ROS.


  1. Corral-Debrinski, M., Horton, T., Lott, M.T., Shoffner, J.M., Beal, M.F., and Wallace, D.C. (1992). Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat Genet 2, 324- 329.
  2. Kroemer, G., and Reed, J.C. (2000). Mitochondrial control of cell death. Nat Med 6, 513-519.
  3. Lee, C.M., Chung, S.S., Kaczkowski, J.M., Weindruch, R., and Aiken, J.M. (1993). Multiple mitochondrial DNA deletions associated with age in skeletal muscle of rhesus monkeys. J Gerontol 48, B201-205.
  4. Melov, S., Hinerfeld, D., Esposito, L., and Wallace, D.C. (1997). Multiorgan characterization of mitochondrial genomic rearrangements in ad libitum and caloric restricted mice show striking somatic mitochondrial DNA rearrangements with age. Nucleic Acids Res 25, 974-982.
  5. Pollack, M., Phaneuf, S., Dirks, A., and Leeuwenburgh, C. (2002). The role of apoptosis in the normal aging brain, skeletal muscle, and heart. Ann N Y Acad Sci 959, 93-107.
  6. Wang, Y., Michikawa, Y., Mallidis, C., Bai, Y., Woodhouse, L., Yarasheski, K.E., Miller, C.A., Askanas, V., Engel, W.K., Bhasin, S., et al. (2001). Muscle- specific mutations accumulate with aging in critical human mtDNA control sites for replication. Proc Natl Acad Sci U S A 98, 4022-4027.
  7. Kerr, J.F., Wyllie, A.H., and Currie, A.R. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 239-257.
  8. Khaidakov, M., Heflich, R.H., Manjanatha, M.G., Myers, M.B., and Aidoo, A. (2003). Accumulation of point mutations in mitochondrial DNA of aging mice. Mutat Res 526, 1-7.
  9. Kim, T., Thu, V.T., Han, I.Y., Youm, J.B., Kim, E., Kang, S.W., Kim, Y.W., Lee, J.H., and Joo, H. (2008). Does strong hypertrophic condition induce fast mitochondrial DNA mutation of rabbit heart? Mitochondrion 8, 279-283.
  10. Kujoth, G.C., Leeuwenburgh, C., and Prolla, T.A. (2006). Mitochondrial DNA mutations and apoptosis in mammalian aging. Cancer Res 66, 7386-7389.
  11. Vieira, H.L., Belzacq, A.S., Haouzi, D., Bernassola, F., Cohen, I., Jacotot, E., Ferri, K.F., El Hamel, C., Bartle, L.M., Melino, G., et al. (2001). The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene 20, 4305-4316.
  12. von Kleist-Retzow, J.C., Schauseil-Zipf, U., Michalk, D.V., and Kunz, W.S. (2003). Mitochondrial diseases--an expanding spectrum of disorders and affected genes. Exp Physiol 88, 155-166.
  13. DiMauro, S., and Schon, E.A. (2001). Mitochondrial DNA mutations in human disease. Am J Med Genet 106, 18-26.
  14. Holt, I.J., Harding, A.E., Petty, R.K., and Morgan-Hughes, J.A. (1990). A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 46, 428-433.
  15. Hirano, M., Davidson, M., and DiMauro, S. (2001). Mitochondria and the heart. Curr Opin Cardiol 16, 201-210.
  16. Larsson, N.G., and Oldfors, A. (2001). Mitochondrial myopathies. Acta Physiol Scand 171, 385-393.
  17. Wittenhagen, L.M., and Kelley, S.O. (2003). Impact of disease-related mitochondrial mutations on tRNA structure and function. Trends Biochem Sci 28, 605-611.
  18. Schon, E.A. (2003). Tales from the crypt. J Clin Invest 112, 1312-1316.
  19. Graff, C., Bui, T.H., and Larsson, N.G. (2002). Mitochondrial diseases. Best Pract Res Clin Obstet Gynaecol 16, 715-728.
  20. He, L., Chinnery, P.F., Durham, S.E., Blakely, E.L., Wardell, T.M., Borthwick, G.M., Taylor, R.W., and Turnbull, D.M. (2002). Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR. Nucleic Acids Res 30, e68.
  21. Wei, Y.H., and Lee, H.C. (2002). Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging. Exp Biol Med (Maywood) 227, 671-682.
  22. Brandon, M.C., Lott, M.T., Nguyen, K.C., Spolim, S., Navathe, S.B., Baldi, P., and Wallace, D.C. (2005). MITOMAP: a human mitochondrial genome database-2004 update. Nucleic Acids Res 33, D611-613.
  23. Chen, T.J., Boles, R.G., and Wong, L.J. (1999). Detection of mitochondrial DNA mutations by temporal temperature gradient gel electrophoresis. Clin Chem 45, 1162-1167.
  24. Chinnery, P.F., Howell, N., Andrews, R.M., and Turnbull, D.M. (1999). Clinical mitochondrial genetics. J Med Genet 36, 425-436.
  25. Swerdlow, R.H. (2002). Mitochondrial DNA--related mitochondrial dysfunction in neurodegenerative diseases. Arch Pathol Lab Med 126, 271-280.
  26. DiMauro, S., and Andreu, A.L. (2000). Mutations in mtDNA: are we scraping the bottom of the barrel? Brain Pathol 10, 431-441.
  27. Wong, L.J., and Senadheera, D. (1997). Direct detection of multiple point mutations in mitochondrial DNA. Clin Chem 43, 1857-1861.
  28. Maechler, P., and Wollheim, C.B. (2001). Mitochondrial function in normal and diabetic beta-cells. Nature 414, 807-812.
  29. Moraes, C.T., Atencio, D.P., Oca-Cossio, J., and Diaz, F. (2003). Techniques and pitfalls in the detection of pathogenic mitochondrial DNA mutations. J Mol Diagn 5, 197-208.
  30. Schon, E.A., and DiMauro, S. (2003). Medicinal and genetic approaches to the treatment of mitochondrial disease. Curr Med Chem 10, 2523- 2533.
  31. Bindoff, L. (2003). Mitochondria and the heart. Eur Heart J 24, 221-224.
  32. Liang, M.H., and Wong, L.J. (1998). Yield of mtDNA mutation analysis in 2,000 patients. Am J Med Genet 77, 395-400.<395::AID-AJMG8>3.0.CO;2-M
  33. Scaglia, F., Scheuerle, A.E., Towbin, J.A., Armstrong, D.L., Sweetman, L., and Wong, L.J. (2002). Neonatal presentation of ventricular tachycardia and a Reye-like syndrome episode associated with disturbed mitochondrial energy metabolism. BMC Pediatr 2, 12.
  34. Shanske, S., Tang, Y., Hirano, M., Nishigaki, Y., Tanji, K., Bonilla, E., Sue, C., Krishna, S., Carlo, J.R., Willner, J., et al. (2002). Identical mitochondrial DNA deletion in a woman with ocular myopathy and in her son with pearson syndrome. Am J Hum Genet 71, 679-683.
  35. Takeda, N. (2003). Cardiomyopathy: molecular and immunological aspects (review). Int J Mol Med 11, 13-16.
  36. Chomyn, A., Enriquez, J.A., Micol, V., Fernandez-Silva, P., and Attardi, G. (2000). The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes. J Biol Chem 275, 19198-19209.
  37. A3243G,
  38. Liu, V.W., Zhang, C., and Nagley, P. (1998). Mutations in mitochondrial DNA accumulate differentially in three different human tissues during ageing. Nucleic Acids Res 26, 1268-1275.
  39. Majamaa-Voltti, K., Peuhkurinen, K., Kortelainen, M.L., Hassinen, I.E., and Majamaa, K. (2002). Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G. BMC Cardiovasc Disord 2, 12.
  40. Menotti, F., Brega, A., Diegoli, M., Grasso, M., Modena, M.G., and Arbustini, E. (2004). A novel mtDNA point mutation in tRNA(Val) is associated with hypertrophic cardiomyopathy and MELAS. Ital Heart J 5, 460-465.
  41. Shin, W.S., Tanaka, M., Suzuki, J., Hemmi, C., and Toyo-oka, T. (2000). A novel homoplasmic mutation in mtDNA with a single evolutionary origin as a risk factor for cardiomyopathy. Am J Hum Genet 67, 1617- 1620.
  42. Ruppert, V., Nolte, D., Aschenbrenner, T., Pankuweit, S., Funck, R., and Maisch, B. (2004). Novel point mutations in the mitochondrial DNA detected in patients with dilated cardiomyopathy by screening the whole mitochondrial genome. Biochem Biophys Res Commun 318, 535-543.
  43. Mitomap, .
  44. Neuromuscular Home Page,
  45. Casali, C., d'Amati, G., Bernucci, P., DeBiase, L., Autore, C., Santorelli, F.M., Coviello, D., and Gallo, P. (1999). Maternally inherited cardiomyopathy: clinical and molecular characterization of a large kindred harboring the A4300G point mutation in mitochondrial deoxyribonucleic acid. J Am Coll Cardiol 33, 1584-1589.
  46. Mimaki, M., Ikota, A., Sato, A., Komaki, H., Akanuma, J., Nonaka, I., and Goto, Y. (2003). A double mutation (G11778A and G12192A) in mitochondrial DNA associated with Leber's hereditary optic neuropathy and cardiomyopathy. J Hum Genet 48, 47-50.
  47. Mimaki, M., Ikota, A., Sato, A., Komaki, H., Akanuma, J., Nonaka, I., and Goto, Y. (2003). A double mutation (G11778A and G12192A) in mitochondrial DNA associated with Leber's hereditary optic neuropathy and cardiomyopathy. J Hum Genet 48, 47-50.
  48. Arbustini, E., Fasani, R., Morbini, P., Diegoli, M., Grasso, M., Dal Bello, B., Marangoni, E., Banfi, P., Banchieri, N., Bellini, O., et al. (1998). Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure. Heart 80, 548-558.
  49. Kajander, O.A., Karhunen, P.J., and Jacobs, H.T. (2002). The relationship between somatic mtDNA rearrangements, human heart disease and aging. Hum Mol Genet 11, 317-324.
  50. Levitsky, S., Laurikka, J., Stewart, R.D., Campos, C.T., Lahey, S.J., and McCully, J.D. (2003). Mitochondrial DNA deletions in coronary artery bypass grafting patients. Eur J Cardiothorac Surg 24, 777-784.
  51. Arai, T., Nakahara, K., Matsuoka, H., Sawabe, M., Chida, K., Matsushita, S., Takubo, K., Honma, N., Nakamura, K., Izumiyama, N., et al. (2003). Age-related mitochondrial DNA deletion in human heart: its relationship with cardiovascular diseases. Aging Clin Exp Res 15, 1-5.
  52. Crimi, M., Galbiati, S., Perini, M.P., Bordoni, A., Malferrari, G., Sciacco, M., Biunno, I., Strazzer, S., Moggio, M., Bresolin, N., et al. (2003). A mitochondrial tRNA(His) gene mutation causing pigmentary retinopathy and neurosensorial deafness. Neurology 60, 1200-1203.
  53. Tsuboi, M., Hisatome, I., Morisaki, T., Tanaka, M., Tomikura, Y., Takeda, S., Shimoyama, M., Ohtahara, A., Ogino, K., Igawa, O., et al. (2001). Mitochondrial DNA deletion associated with the reduction of adenine nucleotides in human atrium and atrial fibrillation. Eur J Clin Invest 31, 489-496.
  54. Majamaa, K., Moilanen, J.S., Uimonen, S., Remes, A.M., Salmela, P.I., Karppa, M., Majamaa-Voltti, K.A., Rusanen, H., Sorri, M., Peuhkurinen, K.J., et al. (1998). Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am J Hum Genet 63, 447-454.
  55. Ricchetti, M., Fairhead, C., and Dujon, B. (1999). Mitochondrial DNA repairs double-strand breaks in yeast chromosomes. Nature 402, 96-100.
  56. Levinger, L., Morl, M., and Florentz, C. (2004). Mitochondrial tRNA 3' end metabolism and human disease. Nucleic Acids Res 32, 5430-5441.
  57. Maassen, J.A., LM, T.H., Van Essen, E., Heine, R.J., Nijpels, G., Jahangir Tafrechi, R.S., Raap, A.K., Janssen, G.M., and Lemkes, H.H. (2004). Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes 53 Suppl 1, S103-109.
  58. Kroemer, G., Galluzzi, L., and Brenner, C. (2007). Mitochondrial membrane permeabilization in cell death. Physiol Rev 87, 99-163.
  59. Halestrap, A.P., and Brenner, C. (2003). The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Curr Med Chem 10, 1507-1525.
  60. Brenner, C., and Grimm, S. (2006). The permeability transition pore complex in cancer cell death. Oncogene 25, 4744-4756.
  61. Schein, S.J., Colombini, M., and Finkelstein, A. (1976). Reconstitution in planar lipid bilayers of a voltage-dependent anion-selective channel obtained from paramecium mitochondria. J Membr Biol 30, 99-120.
  62. Colombini, M. (1979). A candidate for the permeability pathway of the outer mitochondrial membrane. Nature 279, 643-645.
  63. Benz, R. (1994). Permeation of hydrophilic solutes through mitochondrial outer membranes: review on mitochondrial porins. Biochim Biophys Acta 1197, 167-196.
  64. Hodge, T., and Colombini, M. (1997). Regulation of metabolite flux through voltage-gating of VDAC channels. J Membr Biol 157, 271-279.
  65. Brustovetsky, N., Brustovetsky, T., Jemmerson, R., and Dubinsky, J.M. (2002). Calcium-induced cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membrane. J Neurochem 80, 207-218.
  66. Hunter, D.R., and Haworth, R.A. (1979). The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch Biochem Biophys 195, 453-459.
  67. Haworth, R.A., and Hunter, D.R. (1979). The Ca2+-induced membrane transition in mitochondria. II. Nature of the Ca2+ trigger site. Arch Biochem Biophys 195, 460-467.
  68. Ichas, F., and Mazat, J.P. (1998). From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochim Biophys Acta 1366, 33-50.
  69. Armstrong, J.S., Yang, H., Duan, W., and Whiteman, M. (2004). Cytochrome bc(1) regulates the mitochondrial permeability transition by two distinct pathways. J Biol Chem 279, 50420-50428.
  70. Schinder, A.F., Olson, E.C., Spitzer, N.C., and Montal, M. (1996). Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J Neurosci 16, 6125-6133.
  71. Brustovetsky, N., Brustovetsky, T., Purl, K.J., Capano, M., Crompton, M., and Dubinsky, J.M. (2003). Increased susceptibility of striatal mitochondria to calcium-induced permeability transition. J Neurosci 23, 4858- 4867.
  72. Crompton, M. (1999). The mitochondrial permeability transition pore and its role in cell death. Biochem J 341 ( Pt 2), 233-249.
  73. Beutner, G., Ruck, A., Riede, B., Welte, W., and Brdiczka, D. (1996). Complexes between kinases, mitochondrial porin and adenylate translocator in rat brain resemble the permeability transition pore. FEBS Lett 396, 189-195.
  74. Galat, A., and Metcalfe, S.M. (1995). Peptidylproline cis/trans isomerases. Prog Biophys Mol Biol 63, 67-118.
  75. Galat, A., and Metcalfe, S.M. (1995). Peptidylproline cis/trans isomerases. Prog Biophys Mol Biol 63, 67-118.
  76. Halestrap, A.P., Woodfield, K.Y., and Connern, C.P. (1997). Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J Biol Chem 272, 3346-3354.
  77. Schlatter, D., Thoma, R., Kung, E., Stihle, M., Muller, F., Borroni, E., Cesura, A., and Hennig, M. (2005). Crystal engineering yields crystals of cyclophilin D diffracting to 1.7 A resolution. Acta Crystallogr D Biol Crystallogr 61, 513-519.
  78. Ploszaj, T., Robaszkiewicz, A., and Witas, H. (2010). [Oxidative damage of mitochondrial DNA: the result or consequence of enhanced generation of reactive oxygen species]. Postepy Biochem 56, 139-146.
  79. Vieira, H., and Kroemer, G. (2003). Mitochondria as targets of apoptosis regulation by nitric oxide. IUBMB Life 55, 613-616.
  80. Dai, D.F., Chen, T., Wanagat, J., Laflamme, M., Marcinek, D.J., Emond, M.J., Ngo, C.P., Prolla, T.A., and Rabinovitch, P.S. (2010). Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria. Aging Cell 9, 536- 544.